< Back to Listing
journal White Papers
Feb 2021 | By Dr Arbinder Singal, Dr. Sonal Jain

Role of Insurance in Digital Therapeutics: Providing a Reliable and Affordable Treatment Approach to Policyholders

Digital therapeutics startups, payers, and other stakeholders are getting on board for transforming the treatment standards. Nowadays, digital therapeutics has expanded its horizons to evidence-based wellness, chronic diseases such as diabetes, and sleep disorder apps. For digital therapeutics companies investing in novel products, the lack of public health insurance coverage is a major limiting factor.

Read full paper